Exam #5 partial guide
Digestive Enzymes and GI Physiology
Pepsin and Proteases:
Pepsin is secreted by chief cells in the gastric mucosa as pepsinogen (an inactive zymogen).
Pepsinogen is activated to pepsin in an acidic environment with a pH of created by hydrochloric acid ().
Pepsin breaks down complex protein molecules into smaller peptide chains and amino acids.
Pancreatic proteases (including trypsin, chymotrypsin, and carboxypeptidase) further digest peptides into free amino acids within the small intestine.
Lipase:
Secreted primarily by the exocrine pancreas (pancreatic lipase) into the duodenum.
Cleaves dietary triglycerides into free fatty acids and monoglycerides.
Efficient action requires bile salts synthesized by the liver and stored in the gallbladder to emulsify large fat globules.
Amylase:
Salivary amylase (ptyalin) is secreted by salivary glands to initiate starch and polysaccharide digestion in the oral cavity.
Pancreatic amylase is secreted into the duodenum to complete carbohydrate breakdown, hydrolyzing starches into disaccharides and trisaccharides.
Endoscopy, Colonoscopy, and Capsule Endoscopy
Esophagogastroduodenoscopy (EGD) and Colonoscopy Preparation:
EGD Preparation: Patient must remain NPO (nothing by mouth) for at least prior to the procedure to lower aspiration risk and permit full mucosal visualization.
Colonoscopy Preparation: Strict clear liquid diet for pre-procedure, followed by oral bowel cleansing solutions (e.g., polyethylene glycol) to evacuate bowel contents until stool effluent is clear-to-yellow liquid. Fasting (NPO) status is maintained for prior to colonoscopy.
Patient Positioning:
EGD Positioning: Left lateral Sims position to facilitate oral drainage, reduce aspiration risk, and allow scope entry.
Colonoscopy Positioning: Left side-lying position (Sims position) with knees flexed toward the chest.
Sedation and Analgesia:
Procedures utilize moderate (conscious) sedation using IV agents such as midazolam (short-acting benzodiazepine) combined with opioids (e.g., fentanyl) or propofol.
Continuous nursing assessment of airway patency, pulse oximetry, cardiac rhythm, respiratory rate, blood pressure, and depth of sedation is required during and after the procedure.
Capsule Endoscopy:
Mechanism and Utility: The patient swallows a wireless, battery-powered camera capsule approximately the size of a large vitamin capsule. As it travels via natural peristalsis, it takes thousands of high-resolution video images transmitted to a data receiver worn on a belt around the patient's waist.
Diagnostic Indication: Visualizes the entire mucosal surface of the small intestine—an area beyond the anatomical reach of standard upper EGD and lower colonoscopy—to identify obscure gastrointestinal bleeding, occult blood loss, Crohn's disease, or intestinal tumors.
Patient Education:
Maintain fasting (NPO) for before swallowing the capsule.
No clear liquids or foods for post-ingestion; clear liquids allowed after ; light snack or meal permitted after .
Wear the recording belt and receiver equipment for the entire testing duration.
The capsule is single-use and naturally excreted in stool; the patient does not need to retrieve the capsule, but must return the data recorder belt to the clinic.
Avoid Magnetic Resonance Imaging (MRI) studies until the capsule has been fully passed from the body.
Abdominal Assessment and Stress Effects
Sequence of Abdominal Assessment:
The precise order of physical assessment for the abdomen is: Inspection, Auscultation, Percussion, Palpation.
Sequence Rationale: Percussion and palpation stimulate smooth muscle contraction and bowel peristalsis, which can distort or artificially alter baseline bowel sounds if performed before auscultation.
Manifestations of Upper and Lower GI Bleeding:
Upper GI Bleed:
Emesis: Bright red blood (hematemesis) indicates active, ongoing bleeding above the ligament of Treitz. "Coffee-ground" emesis indicates blood exposed to gastric hydrochloric acid, converting hemoglobin to brown-black hematin.
Stool: Melena presents as dark, tarry, sticky, foul-smelling stool caused by bacterial degradation and enzymatic oxidation of hemoglobin during transit through the upper GI tract.
Lower GI Bleed:
Stool: Hematochezia presents as bright red or maroon blood per rectum, indicating bleeding originating in the colon, rectum, or anus (or rapid transit upper GI hemorrhage).
Effects of Stress on the Gastrointestinal System:
Severe physiological or psychological stress triggers sympathetic nervous system dominance, causing vasoconstriction of splanchnic circulation and reduced mucosal blood flow.
Ischemia impairs mucosal tissue protection, bicarbonate secretion, and epithelial repair, predisposing to stress-related mucosal disease (SRMD), acute stress ulcers (such as Cushing's ulcers associated with elevated intracranial pressure or Curling's ulcers associated with severe thermal burns), hyperacidity, delayed gastric emptying, and gastrointestinal mucosal barrier dysfunction.
Intrinsic Factor and Pernicious Anemia
Intrinsic Factor Source and Function:
Intrinsic factor is a specialized glycoprotein produced and released by parietal cells located in the mucosa of the stomach gastric fundus and body.
Essential Role: Binds directly to dietary Vitamin B12 (cobalamin) in the small intestine, forming a complex that protects the vitamin from degradation and binds to specific receptors in the terminal ileum for absorption into systemic circulation.
Causes of Intrinsic Factor Deficiency:
Autoimmune destruction of parietal cells or intrinsic factor itself (Pernicious Anemia).
Surgical interventions including total or partial gastrectomy, gastric bypass surgery, or extensive sleeve gastrectomy.
Chronic autoimmune gastritis (Type A gastritis) leading to mucosal atrophy.
Signs and Symptoms of Intrinsic Factor Deficiency:
Hematologic Signs: Macrocytic megaloblastic anemia, severe fatigue, generalized weakness, pallor, mild jaundice, sore and shiny smooth "beefy red" tongue (glossitis), stomatitis, anorexia.
Neurologic Signs: Bilateral peripheral paresthesias (numbness and tingling in hands and feet), loss of vibratory sensation and proprioception, ataxia, unsteadiness, positive Romberg test, altered mental status, memory loss, depression, or psychosis (neurologic damage becomes irreversible if treatment is delayed).
Pernicious Anemia Treatment:
Lifelong Vitamin B12 replacement therapy.
Intramuscular (IM) or deep subcutaneous cyanocobalamin injections (typically daily or weekly during initial loading, followed by monthly for life).
High-dose oral Vitamin B12 (e.g., daily) or sublingual/intranasal formulations may be utilized if passive mucosal absorption paths are functioning.
Major Organs of the Gastrointestinal System
Stomach:
Acts as a temporary reservoir that mixes and churns food with gastric juices to create chyme.
Secretes hydrochloric acid (parietal cells) to lower pH and digest proteins, pepsinogen (chief cells), intrinsic factor (parietal cells), and protective mucus (mucous neck cells).
Controls the gradual release of chyme into the duodenum via the pyloric sphincter.
Small Intestine:
Divided into three structural segments: Duodenum, Jejunum, and Ileum.
Primary anatomical site for enzymatic digestion and nutrient absorption (carbohydrates, proteins, fats, vitamins, minerals, and water).
Features structural adaptations (circular folds, villi, and microvilli brush border) to maximize absorptive surface area.
Large Intestine (Colon):
Composed of cecum, appendix, ascending colon, transverse colon, descending colon, sigmoid colon, rectum, and anal canal.
Absorbs remaining water, liquid content, and essential electrolytes (sodium and chloride).
Houses intestinal flora that synthesize essential vitamins (such as Vitamin K and B-complex vitamins).
Formulates, stores, and eliminates solid fecal matter via defecation.
Gallbladder:
Concentrates and stores bile produced continuously by hepatocytes in the liver.
Contracts in response to cholecystokinin (CCK) released by the duodenum when fatty chyme enters, extruding bile into the common bile duct and duodenum to emulsify fats.
Pancreas:
Exocrine Function: Acinar cells produce alkaline pancreatic juice containing bicarbonate (to neutralize acidic stomach chyme) and essential digestive enzymes (pancreatic amylase, lipase, trypsinogen, chymotrypsinogen) delivered into the duodenum via the pancreatic duct.
Endocrine Function: Islets of Langerhans produce hormones (insulin from beta cells, glucagon from alpha cells) released directly into the blood stream to regulate systemic carbohydrate metabolism and glucose levels.
Helicobacter Pylori (H. Pylori) Infection
Pathophysiology:
Gram-negative, spiral microaerophilic bacterium that colonizes the human gastric mucosa.
Produces urease enzyme, hydrolyzing urea into ammonia and carbon dioxide. Ammonia buffers gastric acid, allowing bacterial survival in low pH, while direct bacterial cytotoxins (VacA, CagA) destroy protective mucus layers and cause mucosal damage and chronic inflammation.
Diagnostic Testing:
Urea Breath Test: Patient swallows radiolabeled urea; if H. pylori is active, bacterial urease cleaves urea, generating labeled exhaled and measured in breath samples. (Must stop PPIs and antibiotics prior).
Stool Antigen Test: Detects H. pylori antigens in stool samples to confirm active infection and verify eradication post-treatment.
Serum Antibody (Serology) Test: Identifies circulating IgG antibodies; cannot distinguish active infection from past exposure.
Endoscopic Biopsy (EGD): Gold standard diagnostic procedure involving mucosal biopsy for histological examination, rapid urease test (CLOtest), or culture.
Signs and Symptoms:
Epigastric burning or gnawing abdominal pain, dyspepsia, indigestion, abdominal bloating, belching, early satiety, nausea, vomiting, anorexia, unexplainable weight loss.
Complications and Related Conditions:
Chronic type B gastritis, Peptic Ulcer Disease (responsible for up to of duodenal ulcers and of gastric ulcers), Mucosa-Associated Lymphoid Tissue (MALT) gastric lymphoma, gastric adenocarcinoma.
Treatment Regimens:
Triple Therapy Regimen (for ):
Proton Pump Inhibitor (PPI) (e.g., omeprazole twice daily).
Clarithromycin ( twice daily).
Amoxicillin ( twice daily) OR Metronidazole ( twice daily if penicillin-allergic).
Quadruple Therapy Regimen (for ):
Proton Pump Inhibitor (PPI).
Bismuth subsalicylate.
Metronidazole.
Tetracycline.
Peptic Ulcer Disease and Ulcer Classification
Definition:
Erosion or ulcerated lesion in the mucosal lining of the upper gastrointestinal tract (stomach or duodenum) penetrating through the muscularis mucosae, caused by an imbalance between aggressive factors (gastric acid, pepsin, H. pylori, NSAIDs) and protective mucosal defenses.
Comparison Between Duodenal and Gastric Ulcers:
Duodenal Ulcers:
Timing of Pain: Occurs after a meal, and frequently awakens the patient in the middle of the night (between and ) when stomach acid empties into the duodenum without food buffer.
Pain Relief: Pain is relieved by food ingestion or antacids.
Clinical Appearance: Patients are usually well-nourished and may gain weight due to frequent eating for pain relief.
Relative Incidence: Accounts for approximately of peptic ulcers.
Gastric Ulcers:
Timing of Pain: Occurs after eating or immediately following food intake.
Pain Exacerbation: Food intake worsens the pain; antacids provide minimal relief.
Clinical Appearance: Patients are often malnourished and exhibit weight loss due to fear of pain associated with eating.
Relative Incidence: Less common than duodenal ulcers, with higher malignant potential.
Complications of Peptic Ulcers:
Hemorrhage: Most frequent complication; ranges from slow occult blood loss to massive hematemesis and melena.
Perforation: Most lethal complication; erosion through the entire ulcer wall releases gastric/duodenal contents into the peritoneal cavity, causing sudden peritonitis.
Gastric Outlet Obstruction: Mechanical blockage due to scarring, edema, and inflammation near the pylorus.
Gastroesophageal Reflux Disease (GERD) and Barrett's Esophagus
Definition of GERD:
Chronic gastrointestinal disorder caused by retrograde flow of gastric and duodenal contents into the esophagus, producing symptoms and esophageal mucosal damage due to transient or permanent lower esophageal sphincter (LES) relaxation/incompetence.
Triggers and Risk Factors:
Foods that decrease LES tone: High-fat foods, chocolate, caffeine, alcohol, peppermint, citrus fruits, tomatoes, carbonated beverages.
Lifestyle factors: Smoking, obesity, pregnancy, tight clothing around abdomen, large meals, lying supine within of eating.
Medications: Calcium channel blockers, nitrates, anticholinergics, NSAIDs, progesterone.
Symptoms and Complications of GERD:
Symptoms: Pyrosis (heartburn), acid regurgitation, dysphagia (difficulty swallowing), odynophagia (painful swallowing), hyper-salivation (water brash), chronic throat clearing, morning hoarseness, dry cough, asthma-like symptoms, non-cardiac chest pain.
Complications: Esophagitis, esophageal strictures (scar tissue leading to narrowing), esophageal ulcers, upper GI bleeding, Barrett's Esophagus.
GERD Treatment Strategies:
Lifestyle Interventions: Elevate the head of the bed using blocks or a wedge pillow, maintain ideal body weight, avoid eating within of bedtime, eat small frequent meals, refrain from tobacco and alcohol.
Pharmacotherapy:
Antacids (e.g., calcium carbonate, aluminum/magnesium hydroxide) for immediate neutralizing relief.
Histamine-2 Receptor Antagonists (, e.g., famotidine) to reduce gastric acid production.
Proton Pump Inhibitors (PPIs, e.g., omeprazole, pantoprazole) for potent long-term acid suppression and mucosal healing.
Prokinetic agents (e.g., metoclopramide) to accelerate gastric emptying.
Surgical Intervention: Laparoscopic Nissen Fundoplication (wrapping the gastric fundus around the lower esophagus to reinforce the LES).
Barrett's Esophagus:
Pathophysiology and Cause: Severe complication of long-standing, untreated GERD wherein normal stratified squamous epithelium lining the lower esophagus undergoes metaplasia, transforming into columnar epithelium with goblet cells (intestinal metaplasia) to withstand acid exposure.
Clinical Significance and Complications: Precancerous lesion that significantly increases the risk of developing Esophageal Adenocarcinoma. Requires lifelong surveillance EGD endoscopy with biopsy every .
Gastritis and Oral Cancer
Gastritis:
Definition: Inflammation of the gastric mucosa, which may present as acute (transient) or chronic (progressive atrophy).
Risk Factors: Heavy use of NSAIDs or aspirin, H. pylori infection, excessive alcohol consumption, severe physiologic stress (burns, trauma, sepsis), autoimmune conditions (Pernicious Anemia), smoking, systemic corticosteroids, radiation exposure, age.
Signs and Symptoms: Epigastric tenderness or gnawing pain, nausea, vomiting, anorexia, feeling of fullness after eating, hematemesis, melena, or occult blood loss.
Oral Cancer:
Risk Factors: Heavy tobacco use (cigarettes, cigars, pipes, smokeless/chewing tobacco), excessive alcohol consumption (synergistic risk when combined with tobacco), Human Papillomavirus (HPV-16 strain) infection, prolonged exposure to ultraviolet radiation (lip cancer), poor oral hygiene, chronic mucosal irritation, male sex, age over .
Signs and Symptoms: Non-healing sore, ulcer, or lesion in the mouth lasting longer than ; leukoplakia (thick white non-scrapeable patches); erythroplakia (red velvety patches with high dysplasia risk); oral pain or burning; dysphagia; difficulty moving jaw or tongue; painless lump or induration in neck/cheek; loose teeth; ill-fitting dentures.
Gastrointestinal Bleeding and Peritonitis
Lower vs. Upper Gastrointestinal Bleeding:
Upper GI Bleed Signs: Hematemesis (bright red or dark coffee-ground emesis), melena (black, tarry, sticky, foul stools), epigastric pain or fullness, hyperactive bowel sounds from blood irritation, elevated Blood Urea Nitrogen (BUN) due to protein digestion of blood.
Lower GI Bleed Signs: Hematochezia (bright red or dark maroon rectal blood mixed in stool), tenesmus (painful urgency to defecate), lower abdominal cramping.
Etiology of Bleeding Types:
Hematochezia Causes: Diverticulosis, arteriovenous malformations, internal/external hemorrhoids, anal fissures, inflammatory bowel disease (Ulcerative Colitis, Crohn's), colorectal polyps or carcinomas, or massive rapid upper GI hemorrhage exceeding bowel capacity.
Melena Causes: Peptic ulcer disease, esophageal varices, Mallory-Weiss esophageal tears, erosive gastritis, gastric carcinoma.
Signs of Hemorrhage and Hypovolemic Shock:
Early Signs: Tachycardia (heart rate ), tachypnea, orthostatic changes in blood pressure and heart rate, mild anxiety, cool pale extremities.
Late Signs: Systemic hypotension (systolic BP ), weak thready pulse, oliguria ( urine output) progressing to anuria, delayed capillary refill (), cold clammy cyanotic skin, altered mental status, confusion, lethargy, or loss of consciousness.
Peritonitis:
Causes: Contamination of the sterile peritoneal cavity by chemical toxins or bacteria resulting from GI tract perforation (e.g., perforated peptic ulcer, ruptured appendicitis, diverticulitis, strangulated bowel ischemia, perforated gallbladder, abdominal trauma, continuous ambulatory peritoneal dialysis catheter infection).
Signs and Symptoms: Sudden, severe, diffuse abdominal pain that rapidly localizes; marked rebound tenderness; rigid, board-like abdomen; involuntary muscle guarding; abdominal distension; absent or silent bowel sounds (paralytic ileus); high fever; chills; tachycardia; tachypnea; nausea and vomiting; progression to septic and hypovolemic shock.
Pharmacotherapy: Metronidazole (Flagyl)
Drug Overview and Indications:
Synthetic antibacterial and antiprotozoal agent effective against obligate anaerobic bacteria (e.g., Bacteroides, Clostridium) and protozoa.
Used in combination regimens for H. pylori eradication, treatment of Clostridioides difficile colitis, intra-abdominal infections, and pelvic inflammatory disease.
Patient Education Points:
Absolute Alcohol Avoidance: Strict prohibition of alcohol consumption (including alcoholic beverages, over-the-counter cough syrups containing alcohol, mouthwashes, cooking alcohol) during therapy and for at least () after the final dose.
Disulfiram-like Reaction Risk: Ingestion of alcohol with metronidazole causes acetaldehyde accumulation leading to severe flushing, throbbing headache, violent nausea, profuse vomiting, abdominal cramps, diaphoresis, chest tightness, palpitations, and hypotension.
Administration: Take oral tablets with food or a full glass of milk to decrease GI distress.
Expected Side Effects: Harmless dark or reddish-brown discoloration of urine; metallic, bitter, or unpleasant taste in mouth; dry mouth.
Adherence: Complete the entire prescribed course of antibiotic therapy even if symptoms resolve earlier.
Immediate Adverse Event Reporting: Inform healthcare provider immediately if experiencing neurological side effects such as peripheral neuropathy (paresthesias, numbness, tingling in feet/hands), ataxia, confusion, or seizures.
Post-Gastric Complications: Dumping Syndrome and Gastric Outlet Obstruction
Dumping Syndrome:
Definition and Pathophysiology: A clinical complication occurring following surgical procedures that remove, bypass, or alter the pyloric sphincter (e.g., partial/total gastrectomy, Billroth I, Billroth II, Roux-en-Y gastric bypass, pyloroplasty). Uncontrolled, rapid dumping of hyperosmolar chyme into the small intestine pulls fluid from the intravascular space into the lumen via osmosis.
Risk Factors: History of gastric surgery, vagotomy, bariatric surgical procedures.
Clinical Manifestations:
Early Phase ( after meals): Abdominal pain, epigastric fullness, hyperactive bowel sounds, borborygmi, explosive diarrhea, nausea; systemic vascular collapse symptoms including diaphoresis, flushing, tachycardia, palpitations, dizziness, lightheadedness, syncope.
Late Phase ( after meals): Reactive postprandial hypoglycemia triggered by rapid absorption of simple carbohydrates causing excessive insulin secretion from the pancreas; symptoms include diaphoresis, shakiness, tremors, anxiety, confusion, weakness, hunger.
Dietary and Lifestyle Interventions:
Consume high-protein, high-fat, low-carbohydrate meals.
Eliminate simple sugars, refined carbohydrates, and hypertonic sweets.
Eat small, frequent meals ( meals per day).
Avoid drinking fluids with meals; ingest liquids before or after eating solid food.
Recline or lie down flat in a supine position for after eating to slow gastric transit.
Gastric Outlet Obstruction (GOO):
Definition: Mechanical impedance to gastric emptying at the pylorus or pyloric channel leading to stomach distension.
Etiology: Chronic peptic ulcer disease (scarring, fibrosis, muscle spasm, edema), pyloric stenosis, gastric neoplasms.
Signs and Symptoms: Persistent, non-bilious projectile vomiting containing undigested food ingested hours or days prior; foul-smelling emesis; severe persistent epigastric fullness or pain relieved by vomiting; anorexia; weight loss; visible peristaltic waves in upper abdomen; succession splash heard over stomach upon auscultation; severe hypokalemic, hypochloremic metabolic alkalosis resulting from prolonged loss of hydrochloric acid and potassium through vomiting.
Nursing Interventions and Treatment:
Insert Nasogastric (NG) tube connected to low intermittent suction for gastric decompression, removing retained food/fluids and allowing pyloric edema to subside.
Maintain NPO status and administer IV fluid replacement with isotonic saline and electrolyte replacement (potassium chloride).
Administer IV Proton Pump Inhibitors (PPIs) to reduce stomach acid production and mucosal inflammation.
Endoscopic balloon dilation of the pylorus or surgical intervention (pyloroplasty, gastrojejunostomy) if conservative management fails to relieve obstruction.